AzTrials
AzTrials

Eye DiseasesNCT06812845

Patterns of Eye Diseases Among Patients Attending The Eye Investigation Unit of Sohag University Hospital

An observational study of Eye Diseases, run by Sohag University at 1 site in Egypt.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of the work: is to assess the patterns of eye diseases in patients attending the eye investigation unit of Sohag University Hospital.organize the community education. The main question it aims to answer is DOES eye disease blindness prevalence rate increase in women more than men? What is the rate of glaucoma… Read more about this study

Who is it for?
Any ageHealthy volunteers can take part
Conditions the study is for
Eye Diseases
What is being tested?
eye investigations
How many people
7,000 participants
Where
1 siteEgypt
Study dates
1 Jan 2025to 30 Jun 2026
How long will I take part?
1 Year
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Study population: all patients attending to the eye investigation unit of Sohag University Hospital in the period from January 2025 to December 2025.

Who may be able to join

  • All patients referred to the eye investigation unit from the outpatient clinic of Sohag university hospital, private clinics or health insurance.

Who cannot join

  • Patients unable to measure visual acuity.
  • Patients unable to measure intraocular pressure.
  • Mentally retarded patients.
  • Undiagnosed patients.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

mahmoud AE Dr\ mahmoud abdelwareth contact

01150969875 ext. 093

Mahmoud_abdelwareth_post@med.sohag.edu.eg

mortada AH Prof\ abuzaid, Professor contact

01203324446 ext. 093

Egypt1 site, 1 recruiting
  • Faculty of Medicine in Sohag University

    Sohag, 82524

    mahmoud AE DR\ abdelwareth mohamed, 01150969875 ext. 093, Mahmoud_abdelwareth_post@med.sohagedu.eg

    Mortada AH Prof\ Abozaid, professor, 01203324446 ext. 093

    Recruiting

Other trials in Egypt

About this study

The goal of the work: is to assess the patterns of eye diseases in patients attending the eye investigation unit of Sohag University Hospital.organize the community education. The main question it aims to answer is

  • DOES eye disease blindness prevalence rate increase in women more than men?
  • What is the rate of glaucoma and other ocular diseases that causes irreversible blindness among the attending patients? Patients attending to the eye investigation unit of Sohag University Hospital in the period from January 2025 to December 2025 are being observed in this work to determine the eye diseases prevalence.
Read the detailed description

This type of study is helpful to get an idea about the epidemiology of ocular disorders. It is necessary to organize the community education and ensure early treatment to reduce the prevalence of such diseases in the general population.

  • Aim of the work: is to assess the patterns of eye diseases in patients attending the eye investigation unit of Sohag University Hospital.
  • Study design: observational Cross-Sectional study.3
  • Patients and methods: all patients attending to the eye investigation unit of Sohag University Hospital in the period from January 2025 to December 2025.
  • Inclusion criteria: All patients referred to the eye investigation unit from the outpatient clinic of Sohag university hospital, private clinics or health insurance.
  • Exclusion criteria:
  1. Patients unable to measure visual acuity.
  2. Patients unable to measure intraocular pressure.
  3. Mentally retarded patients.
  4. Undiagnosed patients.
  • Time schedule:
  1. Twelve months for collection of data, writing the review of literature and methodology.
  2. Three months for analysis of data and writing the results.
  3. Three months for writing the discussion and conclusions.
  • ethical considerations:
  1. The study adheres to Tents of Helsinki declaration.
  2. The study will be approved by the ethical committee of the faculty of medicine Sohag University.
  3. An informed written consent will be taken from all of the participants in the study or their guardians
Conditions
Eye Diseases
Being tested
eye investigations
Keywords
patterns of eye disease
Medical subject headings
Eye Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • eye investigationsOther

    Also called visual acuity, IOP measurment, Refraction

    BY data entry ,measuring the visual acuity ,measuring IOP, doing refraction and recording eye investigations results to reach the final diagnosis

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. determine the pattrens of eye diseases among patients attending the eye investigtion unit of sohag university

    recording data of the prevalence of each eye disease among the study group in the period from January 2025 to December 2025 .their percentage in men and women , also in which age group

    Measured: 1. Twelve months for collection of data, writing the review of literature and methodology. 2. Three months for analysis of data and writing the results. 3. Three months for writing the discussion and conclusions.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Feb 2025
  2. Study start1 Jan 2025
  3. Primary completion31 Dec 2025 (estimated)
  4. Study completion30 Jun 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Cross-sectional
Enrolment
7,000 participants (estimated)
Target duration
1 Year
IDs, dates and publications
ClinicalTrials.gov ID
NCT06812845
Sponsor's protocol ID
Soh-Med--25-1-10MS
Status last verified
Feb 2025
First submitted
1 Feb 2025
Last updated
12 Feb 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Eye Diseases, run by Sohag University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 12 Feb 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact mahmoud AE Dr\ mahmoud abdelwareth (01150969875 ext. 093, Mahmoud_abdelwareth_post@med.sohag.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

determine the pattrens of eye diseases among patients attending the eye investigtion unit of sohag university (time frame: 1. Twelve months for collection of data, writing the review of literature and methodology. 2. Three months for analysis of data and writing the results. 3. Three months for writing the discussion and conclusions.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Feb 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in